Indegene appoints Jill DeSimone to Board of Directors
DeSimone was formerly President of US Oncology at Merck
Read MoreAppointments and people articles
Feb 9, 2026 | Appointments
DeSimone was formerly President of US Oncology at Merck
Read MoreFeb 6, 2026 | Appointments
Tansey Chevlen previously spent over 17 years at Amgen in multiple leadership roles
Read MoreJan 29, 2026 | Appointments
Haviland was most recently President and CEO of Blueprint Medicines
Read MoreJan 28, 2026 | Appointments
Lefranc has served at Ipsen since 2013, most recently as Senior Vice President
Read MoreJan 27, 2026 | Appointments
Terri and Mark both have extensive life sciences and consulting experience
Read MoreJan 23, 2026 | Appointments
Ryan’s most recent role was Executive VP and US Head of Digital & Innovation at GCI Health
Read MoreJan 16, 2026 | Appointments
Lee previously held senior roles at ImmPACT Bio, Neogene Therapeutics and AstraZeneca
Read MoreJan 15, 2026 | Appointments
Farrell was previously founder and CEO of two NASDAQ-listed companies
Read MoreJan 14, 2026 | Appointments
Leonard was previously Therapeutic Area Lead for Pfizer’s oncology branch
Read MoreJan 13, 2026 | Appointments
Leftheris has held senior scientific roles at Bristol Myers Squibb and Celgene
Read MoreJan 9, 2026 | Appointments
Wettan has served at Gilead for over 14 years
Read MoreDec 11, 2025 | Appointments
Bertozzi received the 2022 Nobel Prize in Chemistry
Read More
